1. Chen WW, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ, et al. China cardiovascular diseases report 2015: a summary. J Geriatr Cardiol. 2017;14(1):1-10.
2. Nielsen S, Björck L, Berg J, Giang KW, Zverkova Sandström T, et al. Sex-specific trends in 4-year survival in 37 276 men and women with acute myocardial infarction before the age of 55 years in Sweden, 1987-2006: a register-based cohort study. BMJ Open. 2014;4(5):e004598.
3. Dreyer RP, Wang Y, Strait KM, Lorenze NP, D'Onofrio G, Bueno H, et al. Gender differences in the trajectory of recovery in health status among young patients with acute myocardial infarction: results from the variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) study. Circulation. 2015;131(22):1971-80.
4. Cao CF, Ren JY, Zhou XH, Li SF, Chen H. Twenty-year trends in major cardiovascular risk factors in hospitalized patients with acute myocardial infarction in Beijing. Chin Med J (Engl). 2013;126(22):4210-5.
5. Chang J, Liu X and Sun Y. Mortality due to acute myocardial infarction in China from 1987 to 2014: Secular trends and age-period-cohort effects. Int J Cardiol. 2017;227:229-38.
6. Zhao Q, Yang Y, Chen Z, Yu H, Xu H. Changes in characteristics, risk factors, and in-hospital mortality among patients with acute myocardial infarction in the capital of China over 40 years. Int J Cardiol. 2018;265:30-4.
7. Leifheit-Limson EC, D'Onofrio G, Daneshvar M, Geda M, Bueno H, Spertus JA, et al. Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction: The VIRGO Study. J Am Coll Cardiol. 2015;66(19):1949-57.
8. Lichtman JH, Leifheit EC, Safdar B, Bao H, Krumholz HM, Lorenze NP, et al. Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction: Evidence from the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of YoungAMIPatients). Circulation. 2018;137(8):781-90.
9. Wright S, Mabejane R. The 2019 UN high-level meeting on universal health coverage. Lancet. 2019;393(10184):1931.
10. Gibson J. Air pollution, climate change, and health. Lancet Oncol. 2015;16(6):e269.
11. Claeys MJ, Rajagopalan S, Nawrot TS, Brook RD. Climate and environmental triggers of acute myocardial infarction. Eur Heart J. 2017;38(13):955-60.
12. Tonne C, Melly S, Mittleman M, Coull B, Goldberg R, Schwartz J. A case-control analysis of exposure to traffic and acute myocardial infarction. Environ Health Perspect. 2007;115(1):53-7.
13. Kojima S, Michikawa T, Ueda K, Sakamoto T, Matsui K, Kojima T, et al. Asian dust exposure triggers acute myocardial infarction. Eur Heart J. 2017;38(43):3202-8.
14. Wang X, Kindzierski W, Kaul P. Comparison of transient associations of air pollution and AMI hospitalisation in two cities of Alberta, Canada, using a case-crossover design. BMJ Open. 2015;5(11):e009169.
15. Brüske I, Hampel R, Baumgärtner Z, Rückerl R, Greven S, Koenig W, et al. Ambient air pollution and lipoprotein-associated phospholipase A₂ in survivors of myocardial infarction. Environ Health Perspect. 2011;119(7):921-6.
16. Madrigano J, Kloog I, Goldberg R, Coull BA, Mittleman MA, Schwartz J. Long-term exposure to PM2.5 and incidence of acute myocardial infarction. Environ Health Perspect. 2013;121(2):192-6.
17. Chen H, Burnett RT, Copes R, Kwong JC, Villeneuve PJ, Goldberg MS, et al. Ambient Fine Particulate Matter and Mortality among Survivors of Myocardial Infarction: Population-Based Cohort Study. Environ Health Perspec. 2016;124(9): 1421-8.
18. Meier CR, Derby LE, Jick SS, Vasilakis C, Jick H. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA. 1999;281(5):427-31.
19. Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med. 2019;380(2):171-6.
20. Ogbebor O, Odugbemi B, Maheswaran R, Patel K. Seasonal variation in mortality secondary to acute myocardial infarction in England and Wales: a secondary data analysis. BMJ Open. 2018;8(7):e019242.
21. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 1998;351(9114):1467-71.
22. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614-22.
23. Wiesbauer F, Blessberger H, Azar D, Goliasch G, Wagner O, Gerhold L, et al. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age). Eur Heart J. 2009;30(9):1073-9.
24. The Lancet. Modernizing the NHS: leading the way with diabetes. Lancet. 2019; 393(10168):200.
25. Smyth A, O'Donnell M, Lamelas P, Teo K, Rangarajan S, Yusuf S. INTERHEART Investigators. Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study. Circulation. 2016;134(15):1059-67.
26. Smolderen KG, Buchanan DM, Gosch K, Whooley M, Chan PS, Vaccarino V, et al. Depression Treatment and 1-Year Mortality After Acute Myocardial Infarction: Insights From the TRIUMPH Registry (Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status). Circulation. 2017;135(18):1681-9.
27. Gustad LT, Laugsand LE, Janszky I, Dalen H, Bjerkeset O. Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study. Eur Heart J. 2014;35(21):1394-403.
28. Khambaty T, Stewart JC, Gupta SK, Chang CH, Bedimo RJ, Budoff MJ, et al. Association Between Depressive Disorders and Incident Acute Myocardial Infarction in Human Immunodeficiency Virus-Infected Adults: Veterans Aging Cohort Study. JAMA Cardiol. 2016;1(8):929-37.
29. Du H, Li L, Bennett D, Guo Y, Key TJ, Bian Z, et al. China Kadoorie Biobank Study. China Kadoorie Biobank Study. Fresh Fruit Consumption and Major Cardiovascular Disease in China. N Engl J Med. 2016;374(14):1332-43.
30. Kousa A, Havulinna AS, Moltchanova E, Taskinen O, Nikkarinen M, Eriksson J, et al. Calcium:magnesium ratio in local groundwater and incidence of acute myocardial infarctionamong males in rural Finland. Environ Health Perspect. 2006;114(5):730-4.
31. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368(9536):647-58.
32. Sipilä JO, Gunn JM, Kauko T, Rautava P, Kytö V. Association of restaurant smoking ban and the incidence of acute myocardial infarction in Finland. BMJ Open. 2016;6(1):e009320.
33 Chilvers CE, Knibb RC, Armstrong SJ, Woods KL, Logan RF. Post menopausal hormone replacement therapy and risk of acute myocardial infarction--a case control study of women in the East Midlands, UK. Eur Heart J. 2003;24(24): 2197-205.
34. Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008;299(5):532-9.
35. Wang Y, Li J, Zheng X, Jiang Z, Hu S, Wadhera RK, et al. Risk Factors Associated With Major Cardiovascular Events 1 Year After Acute Myocardial Infarction. JAMA Netw Open. 2018;1(4):e181079.
36. Bradley SM, Borgerding JA, Wood GB, Maynard C, Fihn SD. Incidence, Risk Factors, and Outcomes Associated With In-Hospital Acute Myocardial Infarction. JAMA Netw Open. 2019;2(1):e187348.
37. Hu C. C-type hypertension. Eur Heart J. 2019;40(9):715.
38. Hu C, Tkebuchava T, Hu D. Managing acute myocardial infarction in China. Eur Heart J. 2019;40(15):1179-81.
39. Hu C. Grants supporting research in China. Eur Heart J. 2018;39(25):2342-4.
40. Drazen JM, Morrissey S, Campion EW, Jarcho JA. A SPRINT to the Finish. N Engl J Med. 2015;373(22):2174-5.
41. Tang J, Wang J, Huang K, Ye Y, Su T, Qiao L, et al. Cardiac cell-integrated microneedle patch for treating myocardial infarction. Sci Adv. 2018;4(11):eaat9365.
42. Zhang YY, Fu ZY, Wei J, Qi W, Baituola G, Luo J, et al. ALIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption. Science. 2018;360(6393):1087-92.
43. Andreadou I, Cabrera-Fuentes HA, Devaux Y, Frangogiannis NG, Frantz S, Guzik T, et al. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc Res. 2019;115(7):1117-30.
44. Yang CF, Chen YY, Singh JP, Hsu SF, Liu YW, Yang CY, et al. Targeting Protein Tyrosine Phosphatase PTP-PEST for Therapeutic Intervention in Acute Myocardial Infarction. Cardiovasc Res. 2020;116(5):1032-46.
45. Zhang H, Masoudi FA, Li J, Wang Q, Li X, Spertus JA, et al. China PEACE Collaborative Group. National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study. Am Heart J. 2015;170(3):506-15.e1.
46. Xu H, Li W, Yang J, Wiviott SD, Sabatine MS, Peterson ED, et al. CAMI Registry study group. The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China. Am Heart J. 2016;175:193-201.e3.
47. M. Orecchioni et al., Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Science 375, 214-221 (2022).
48. M. Litviňuková et al., Cells of the adult human heart. Nature 588, 466-472 (2020).
49. Zhao X, Yang XX, Ji SZ, Wang XZ, Wang L, Gu CH, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban. Mil Med Res. 2016;3:13.
50. Carrión-Valero F, Quiles-Izquierdo J, González-Monte C, Taberner-Alberola F, Lluch-Rodrigo JA, Chorro FJ, et al. Association between a comprehensive smoking ban and hospitalization for acute myocardial infarction: An observational study in the Autonomous Community of Valencia, Spain. Rev Port Cardiol. 2020;39(2):77-84.